Clinical Guidelines & Pathways


Ophthalmology – Intravitreal Injection Treatment Pathway


Updated May 2024
(previous versions Feb 2020 , June 2021)

View Document

Guideline Categories: Ophthalmology

Guideline Areas: Bedfordshire, Luton, Milton Keynes

Guideline Tags: adalimumab, aflibercept, brolucizumab, dexamathasone, faricimab, fluocinolone, intravitreal, ophthalmology, ranibizumab

Please use the search box to search the whole site if you can't find what you're looking for:

To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net